⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLSA News
Tiziana Life Sciences Ltd. Common Shares
Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function
globenewswire.com
TLSA
Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress
globenewswire.com
TLSA
Multiple Sclerosis Market Competitive Landscape Report 2026: Comprehensive Insights on Over 60 Companies and 75 Drugs by Product Type, Development Stage, Administration Route, and Molecule Type
globenewswire.com
SNY
IMUX
TLSA
BIIB
BMY
TGTX
Multiple Sclerosis Market Competitive Landscape Report 2026: Comprehensive Insights on Over 60 Companies and 75 Drugs by Product Type, Development Stage, Administration Route, and Molecule Type
globenewswire.com
SNY
IMUX
TLSA
BIIB
TGTX
Telia stellt nach Akquisition des Betreibers Telness Seamless OS bereit
businesswire.com
TLSA
Telia to Deploy Seamless OS Following Acquisition of Telness Operator
businesswire.com
TLSA
Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging
globenewswire.com
TLSA
Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging
globenewswire.com
TLSA
Draft decisions of the Annual General Meeting of Shareholders to be held on 24 April 2026
globenewswire.com
TLSA
TCOM
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA
globenewswire.com
TLSA